Review The Emerging Profile of Cross-Resistance among the Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors
Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are widely used to treat HIV-1-infected individuals; indeed read more most first-line antiretroviral therapies typically include one NNRTI in combination with two nucleoside analogs.In 2008, the next-generation NNRTI etravirine was approved for the treatment of HIV-infected antiretroviral ther